129 related articles for article (PubMed ID: 38214579)
1. Borneol-Modified Schisandrin B Micelles Cross the Blood-Brain Barrier To Treat Alzheimer's Disease in Aged Mice.
Li FR; Yu Y; Du YM; Kong L; Liu Y; Wang JH; Chen MH; Liu M; Zhang ZX; Li XT; Ju RJ
ACS Chem Neurosci; 2024 Feb; 15(3):593-607. PubMed ID: 38214579
[No Abstract] [Full Text] [Related]
2. Pep-1&borneol-Bifunctionalized Carmustine-Loaded Micelles Enhance Anti-Glioma Efficacy Through Tumor-Targeting and BBB-Penetrating.
Guo X; Wu G; Wang H; Chen L
J Pharm Sci; 2019 May; 108(5):1726-1735. PubMed ID: 30537472
[TBL] [Abstract][Full Text] [Related]
3. Borneol-modified docetaxel plus tetrandrine micelles for treatment of drug-resistant brain glioma.
Liu Y; Cai JY; Liu Y; Zhang L; Guo RB; Li XT; Ma LY; Kong L
Drug Dev Ind Pharm; 2024 Feb; 50(2):135-149. PubMed ID: 38235554
[TBL] [Abstract][Full Text] [Related]
4. Combination of schisandrin and nootkatone exerts neuroprotective effect in Alzheimer's disease mice model.
Qi Y; Cheng X; Jing H; Yan T; Xiao F; Wu B; Bi K; Jia Y
Metab Brain Dis; 2019 Dec; 34(6):1689-1703. PubMed ID: 31422511
[TBL] [Abstract][Full Text] [Related]
5. Schisandrin ameliorates cognitive deficits, endoplasmic reticulum stress and neuroinflammation in streptozotocin (STZ)-induced Alzheimer's disease rats.
Song L; Piao Z; Yao L; Zhang L; Lu Y
Exp Anim; 2020 Aug; 69(3):363-373. PubMed ID: 32336744
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of dibenzocyclooctadiene lignans from Schisandra chinensis against beta-amyloid and homocysteine neurotoxicity in PC12 cells.
Song JX; Lin X; Wong RN; Sze SC; Tong Y; Shaw PC; Zhang YB
Phytother Res; 2011 Mar; 25(3):435-43. PubMed ID: 20740476
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of schisandrin A, B, and C on Propionibacterium acnes-induced, NLRP3 inflammasome activation-mediated IL-1β secretion and pyroptosis.
Guo M; An F; Yu H; Wei X; Hong M; Lu Y
Biomed Pharmacother; 2017 Dec; 96():129-136. PubMed ID: 28972885
[TBL] [Abstract][Full Text] [Related]
8. Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer's disease.
Sun J; Wei C; Liu Y; Xie W; Xu M; Zhou H; Liu J
Biomaterials; 2019 Mar; 197():417-431. PubMed ID: 30638753
[TBL] [Abstract][Full Text] [Related]
9. Schizandrin A ameliorates cognitive functions via modulating microglial polarisation in Alzheimer's disease mice.
Wang Q; Liu L; Guan H; Zhou Y; Li Q
Pharm Biol; 2021 Dec; 59(1):860-867. PubMed ID: 34214019
[TBL] [Abstract][Full Text] [Related]
10. Schisandrin B alleviates acute oxidative stress via modulation of the Nrf2/Keap1-mediated antioxidant pathway.
Wu Y; Li ZC; Yao LQ; Li M; Tang M
Appl Physiol Nutr Metab; 2019 Jan; 44(1):1-6. PubMed ID: 29742356
[TBL] [Abstract][Full Text] [Related]
11. Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood-brain barrier permeability.
Zhang QL; Fu BM; Zhang ZJ
Drug Deliv; 2017 Nov; 24(1):1037-1044. PubMed ID: 28687052
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of schisandrin B and dimethyl diphenyl bicarboxylate (DDB) on hepatic mitochondrial glutathione redox status in carbon tetrachloride intoxicated mice.
Ip SP; Yiu HY; Ko KM
Mol Cell Biochem; 2000 Feb; 205(1-2):111-4. PubMed ID: 10821428
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of schisandrin B against cyclosporine A-induced nephrotoxicity in vitro and in vivo.
Zhu S; Wang Y; Chen M; Jin J; Qiu Y; Huang M; Huang Z
Am J Chin Med; 2012; 40(3):551-66. PubMed ID: 22745070
[TBL] [Abstract][Full Text] [Related]
14. Schisandrin B Ameliorates ICV-Infused Amyloid β Induced Oxidative Stress and Neuronal Dysfunction through Inhibiting RAGE/NF-κB/MAPK and Up-Regulating HSP/Beclin Expression.
Giridharan VV; Thandavarayan RA; Arumugam S; Mizuno M; Nawa H; Suzuki K; Ko KM; Krishnamurthy P; Watanabe K; Konishi T
PLoS One; 2015; 10(11):e0142483. PubMed ID: 26556721
[TBL] [Abstract][Full Text] [Related]
15. Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles.
Shao M; Yang W; Han G
Int J Nanomedicine; 2017; 12():7121-7130. PubMed ID: 29026305
[TBL] [Abstract][Full Text] [Related]
16. Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling.
Thandavarayan RA; Giridharan VV; Arumugam S; Suzuki K; Ko KM; Krishnamurthy P; Watanabe K; Konishi T
PLoS One; 2015; 10(3):e0119214. PubMed ID: 25742619
[TBL] [Abstract][Full Text] [Related]
17. Angiopep-2 modified dual drug-loaded liposomes with brain targeting functionality mitigate Alzheimer's disease-related symptoms in APP/PS-1 mice.
Zhang X; Shi N; Chen M; Liu M; Ju R; Liu Y; Kong L; Yu Y; Li X
J Drug Target; 2023 Jul; 31(6):634-645. PubMed ID: 37203195
[TBL] [Abstract][Full Text] [Related]
18. Schisandrin B regulates lipid metabolism in subcutaneous adipocytes.
Kwan HY; Wu J; Su T; Chao XJ; Yu H; Liu B; Fu X; Tse AKW; Chan CL; Fong WF; Yu ZL
Sci Rep; 2017 Aug; 7(1):10266. PubMed ID: 28860616
[TBL] [Abstract][Full Text] [Related]
19. Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol.
Meng L; Chu X; Xing H; Liu X; Xin X; Chen L; Jin M; Guan Y; Huang W; Gao Z
Int J Pharm; 2019 Aug; 567():118485. PubMed ID: 31260781
[TBL] [Abstract][Full Text] [Related]
20. Stereoisomers of Schisandrin B Are Potent ATP Competitive GSK-3β Inhibitors with Neuroprotective Effects against Alzheimer's Disease: Stereochemistry and Biological Activity.
Hu XL; Guo C; Hou JQ; Feng JH; Zhang XQ; Xiong F; Ye WC; Wang H
ACS Chem Neurosci; 2019 Feb; 10(2):996-1007. PubMed ID: 29944335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
